Reduced serum levels of adiponectin in elderly patients with major depression (2012)
- Autores:
- Autores USP: FORLENZA, ORESTES VICENTE - FM ; GATTAZ, WAGNER FARID - FM
- Unidade: FM
- DOI: 10.1016/j.jpsychires.2012.04.028
- Assuntos: DEPRESSÃO (FISIOPATOLOGIA); IDOSOS; BIOMARCADORES; ADIPONECTINA; DEPRESSÃO (PATOLOGIA); COGNIÇÃO; CITOCINAS (IMUNOLOGIA)
- Idioma: Inglês
- Imprenta:
- Fonte:
- Título do periódico: Journal of Psychiatric Research
- ISSN: 0022-3956
- Volume/Número/Paginação/Ano: v. 46, n. 8, p.1053-1058, 2012
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
DINIZ, Breno S. et al. Reduced serum levels of adiponectin in elderly patients with major depression. Journal of Psychiatric Research, v. 46, n. 8, p. 1053-1058, 2012Tradução . . Disponível em: https://doi.org/10.1016/j.jpsychires.2012.04.028. Acesso em: 19 set. 2024. -
APA
Diniz, B. S., Teixeira, A. L., Campos, A. C., Miranda, A. S., Rocha, N. P., Talib, L. L., et al. (2012). Reduced serum levels of adiponectin in elderly patients with major depression. Journal of Psychiatric Research, 46( 8), 1053-1058. doi:10.1016/j.jpsychires.2012.04.028 -
NLM
Diniz BS, Teixeira AL, Campos AC, Miranda AS, Rocha NP, Talib LL, Gattaz WF, Forlenza OV. Reduced serum levels of adiponectin in elderly patients with major depression [Internet]. Journal of Psychiatric Research. 2012 ; 46( 8): 1053-1058.[citado 2024 set. 19 ] Available from: https://doi.org/10.1016/j.jpsychires.2012.04.028 -
Vancouver
Diniz BS, Teixeira AL, Campos AC, Miranda AS, Rocha NP, Talib LL, Gattaz WF, Forlenza OV. Reduced serum levels of adiponectin in elderly patients with major depression [Internet]. Journal of Psychiatric Research. 2012 ; 46( 8): 1053-1058.[citado 2024 set. 19 ] Available from: https://doi.org/10.1016/j.jpsychires.2012.04.028 - Three plasma metabolites in elderly patients differentiate mild cognitive impairment and Alzheimer's disease: a pilot study
- Increased soluble TNF receptor 2 in antidepressant-free patients with late-life depression
- Inhibition of phospholipase A2 in rat brain decreases the levels of total Tau protein
- Phospholipase A2 activation as a therapeutic approach for cognitive enhancement in early-stage Alzheimer disease
- Decreased Levels of Circulating Adiponectin in Mild Cognitive Impairment and Alzheimer’s Disease
- Lithium reduces Gsk3b mRNA levels: implications for Alzheimer Disease
- Mild cognitive impairment (part 2): biological markers for diagnosis and prediction of dementia in Alzheimer's disease
- Long-term, low-dose lithium treatment does not impair renal functional in the elderly: A 2 year randomized, placebo-controlled trial followed by single blind extension
- Low Doses of Lithium Changes PKA, AKT and Tau Protein in Cortical and Hippocampal Neurons Cell Culture
- Long-term sertraline treatment increases expression and decreases phosphorylation of glycogen synthase kinase-3B in platelets of patients with late-life major depression
Informações sobre o DOI: 10.1016/j.jpsychires.2012.04.028 (Fonte: oaDOI API)
Como citar
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
